# Electrical Intra-cutaneous Half-sine Stimulation for Optimized Preferential C-fiber Activation

> **NCT05440266** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 24 (actual)

## Conditions studied

- Pain Perception
- Secondary Hyperalgesia

## Interventions

- **DIAGNOSTIC_TEST:** Study Intervention: 25 ms half-sine wave stimulation
- **DIAGNOSTIC_TEST:** Control Intervention: 500 µs rectangular shaped stimulation

## Key facts

- **NCT ID:** NCT05440266
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2022-11-25
- **Final completion:** 2022-11-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05440266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05440266, "Electrical Intra-cutaneous Half-sine Stimulation for Optimized Preferential C-fiber Activation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05440266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*